Clinical significance of heparanase activity in primary resected non-small cell lung cancer - PubMed (original) (raw)
Comparative Study
Clinical significance of heparanase activity in primary resected non-small cell lung cancer
Hidenori Takahashi et al. Lung Cancer. 2004 Aug.
Abstract
Clinicopathological significances of heparanase activity in non-small cell lung cancer (NSCLC) were investigated by analyzing 76 resected specimens of NSCLC. Heparanase activities in NSCLC were significantly higher than non-cancerous lung tissues (P < 0.0001). The heparanase activities of NSCLC were significantly higher in larger diameter tumors (P = 0.0141) or with metastasis to ipsilateral mediastinal lymph nodes (P = 0.0004). The activities of heparanase in primary tumors were increased significantly according to the pathological stage of the progression of the disease (P =0.0009). Among the clinicopathological parameters, histological cell type and evidence of ipsilateral lymph node metastasis showed a significant association with elevated heparanase activities, whereas age, degree of differentiation and tumor diameter did not. Kaplan-Meier curves for overall and disease-free survival demonstrated a significant difference between patients with elevated and non-elevated heparanase activity by log-rank test (P = 0.0145 and 0.0002, respectively). Multivariate analysis showed heparanase activity was an independent factor to influence disease-free survival in our study. These results suggest that heparanase activity could be used as a prognostic indicator for postoperative patients with NSCLC and heparanase might be a promising molecular target for treatment of NSCLC.
Similar articles
- [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
Pfannschmidt J, Muley T, Hoffmann H, Bülzebruck H, Dienemann H. Pfannschmidt J, et al. Dtsch Med Wochenschr. 2006 Nov 24;131(47):2643-8. doi: 10.1055/s-2006-956268. Dtsch Med Wochenschr. 2006. PMID: 17109272 German. - Effect of tumor size on prognosis in patients with non-small cell lung cancer: the role of segmentectomy as a type of lesser resection.
Okada M, Nishio W, Sakamoto T, Uchino K, Yuki T, Nakagawa A, Tsubota N. Okada M, et al. J Thorac Cardiovasc Surg. 2005 Jan;129(1):87-93. doi: 10.1016/j.jtcvs.2004.04.030. J Thorac Cardiovasc Surg. 2005. PMID: 15632829 - Skip metastasis in nonsmall cell lung carcinoma: predictive markers and isolated tumor cells in N1 lymph nodes.
Prenzel KL, Baldus SE, Mönig SP, Tack D, Sinning JM, Gutschow CA, Grass G, Schneider PM, Dienes HP, Hölscher AH. Prenzel KL, et al. Cancer. 2004 May 1;100(9):1909-17. doi: 10.1002/cncr.20165. Cancer. 2004. PMID: 15112272 - Overexpression of dihydrodiol dehydrogenase as a prognostic marker of non-small cell lung cancer.
Hsu NY, Ho HC, Chow KC, Lin TY, Shih CS, Wang LS, Tsai CM. Hsu NY, et al. Cancer Res. 2001 Mar 15;61(6):2727-31. Cancer Res. 2001. PMID: 11289154 - Number of metastatic lymph nodes in resected non-small cell lung cancer predicts patient survival.
Lee JG, Lee CY, Park IK, Kim DJ, Park SY, Kim KD, Chung KY. Lee JG, et al. Ann Thorac Surg. 2008 Jan;85(1):211-5. doi: 10.1016/j.athoracsur.2007.08.020. Ann Thorac Surg. 2008. PMID: 18154813
Cited by
- A comparison of the effects of unfractionated heparin, dalteparin and danaparoid on vascular endothelial growth factor-induced tumour angiogenesis and heparanase activity.
Takahashi H, Ebihara S, Okazaki T, Asada M, Sasaki H, Yamaya M. Takahashi H, et al. Br J Pharmacol. 2005 Oct;146(3):333-43. doi: 10.1038/sj.bjp.0706344. Br J Pharmacol. 2005. PMID: 16041398 Free PMC article. - Genomics of lung cancer may change diagnosis, prognosis and therapy.
Kopper L, Tímár J. Kopper L, et al. Pathol Oncol Res. 2005;11(1):5-10. doi: 10.1007/BF03032399. Epub 2005 Mar 31. Pathol Oncol Res. 2005. PMID: 15800676 Review. - Significance of heparanase in cancer and inflammation.
Vlodavsky I, Beckhove P, Lerner I, Pisano C, Meirovitz A, Ilan N, Elkin M. Vlodavsky I, et al. Cancer Microenviron. 2012 Aug;5(2):115-32. doi: 10.1007/s12307-011-0082-7. Epub 2011 Aug 3. Cancer Microenviron. 2012. PMID: 21811836 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical